《大行報告》美銀證券:疫情延誤賭收復甦 美高梅中國(02282.HK)目標價下調至5.7元
美銀證券發表報告指,美高梅中國(02282.HK)今年第三季經調整物業EBITDA為虧損5.36億元,表現好於該行預期的虧損6.15億元,及市場預期的虧損5.81億元。而季度總收入按年下跌70%至6.87億元,其中貴賓廳按年倒退88%至6,600萬元,中場則按年減少66%至5.93億元。
由於疫情令賭收的復甦延遲,該行將美高梅中國股份目標價由5.9元降至5.7元,評級維持「買入」。美銀認為,集團目前估值仍然吸引,相當於2024年企業價值倍數(EV/EBITDA)為10.4倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.